Novozymes A/S (OTCMKTS:NVZMY) Sees Strong Trading Volume – Should You Buy?

Novozymes A/S (OTCMKTS:NVZMY) saw an uptick in trading volume on Thursday . 81,093 shares were traded during mid-day trading, an increase of 106% from the previous session’s volume of 39,338 shares.The stock last traded at $63.4280 and had previously closed at $61.67.

Analyst Upgrades and Downgrades

Separately, Zacks Research lowered shares of Novozymes A/S from a “strong-buy” rating to a “hold” rating in a research note on Monday, August 25th. One research analyst has rated the stock with a Hold rating, According to data from MarketBeat.com, the company has a consensus rating of “Hold”.

Novozymes A/S Trading Up 2.5%

The firm has a market capitalization of $29.61 billion, a PE ratio of 37.41, a price-to-earnings-growth ratio of 1.21 and a beta of 1.08. The company has a debt-to-equity ratio of 0.26, a current ratio of 1.61 and a quick ratio of 1.00. The company has a fifty day moving average of $62.28 and a 200-day moving average of $65.42.

Novozymes A/S Company Profile

Novozymes A/S produces and sells industrial enzymes, microorganisms, and probiotics in Denmark, rest of Europe, North America, Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company offers protein solutions for the food and beverage industry. It also offers industrial hygiene, drain openers, hard surface, medical cleaning, septic tanks, ware washing, and professional laundry services.